American College of Medical Toxicology and the American Academy of Clinical Toxicology Position Statement: Nalmefene Should Not Replace Naloxone as the Primary Opioid Antidote at This Time

Stolbach, A. I., Mazer-Amirshahi, M., Nelson, L. S., & Cole, J. B. (2024). American College of Medical Toxicology and the American Academy of Clinical Toxicology Position Statement: Nalmefene Should Not Replace Naloxone as the Primary Opioid Antidote at This Time. Journal of Medical Toxicology, 20(1), 64–67. https://doi.org/10.1007/s13181-023-00981-z